Overview
IASLC's Education Committee will present a one-hour live session focused on providing a concise and comprehensive update on the most impactful studies related to thoracic tumors presented during the 2024 ESMO (European Society for Medical Oncology) meeting.
At the end of this webinar, learners should be able to:
- Recall the most relevant studies on thoracic malignancies presented at the 2024 ESMO meeting.
- Update knowledge on the latest advancements in NSCLC, SCLC, and other thoracic tumors.
- Apply evidence-based insights from the 2024 ESMO meeting to improve the clinical management of patients with thoracic malignancies
This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME). The International Association for the Study of Lung Cancer is accredited by the ACCME to provide continuing medical education for physicians.
The International Association for the Study of Lung Cancer designates the live format for this educational activity for a maximum of 1.00 AMA PRA Category 1 Credits™. Physicians should only claim credit commensurate with the extent of their participation in the activity.
At the end of this webinar, learners should be able to:
- Recall the most relevant studies on thoracic malignancies presented at the 2024 ESMO meeting.
- Update knowledge on the latest advancements in NSCLC, SCLC, and other thoracic tumors.
- Apply evidence-based insights from the 2024 ESMO meeting to improve the clinical management of patients with thoracic malignancies
This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME). The International Association for the Study of Lung Cancer is accredited by the ACCME to provide continuing medical education for physicians.
The International Association for the Study of Lung Cancer designates the live format for this educational activity for a maximum of 1.00 AMA PRA Category 1 Credits™. Physicians should only claim credit commensurate with the extent of their participation in the activity.
Share
Participants
Mihaela Aldea
MD, PhD
Thoracic Oncology and Precision Medicine Group Department of Medical Oncology
Gustave Roussy, Villejuif, France
Francesco Passiglia
MD, PhD
Associate Professor, Medical Oncology
University of Turin
Benjamin Besse
MD, PhD
Director of Clinical Research
Gustave Roussy, Villejuif, France
Silvia Novello
MD
Professor of Medical Oncology; Leader of Thoracic Oncology Unit
University of Turin, Italy
San Luigi Hospital in Turin
Ross Soo
MD, MBBS, FRACP
Senior Consultant, Department of Hematology-Oncology
National University Cancer Institute